866-997-4948(US-Canada Toll Free)

Global Oncology Drugs Market Insights, Forecast to 2025

Published By :

QYResearch

Published Date : Sep 2018

Category :

Pharmaceutical

No. of Pages : 119 Pages

This report studies the global market size of Oncology Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Oncology Drugs in these regions.
This research report categorizes the global Oncology Drugs market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

In 2017, the global Oncology Drugs market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Oncology Drugs market based on company, product type, application and key regions.

The various contributors involved in the value chain of Oncology Drugs include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Oncology Drugs include
Novartis A.G
Laboratrio Cristlia
Medley Genomics
F. Hoffmann-La Roche Ltd
Icon Plc.
Sanofi S.A.
Laboratoires Pierre Fabre
Eurofarma Laboratrios S.A.
Ach Laboratrios Farmacuticos S.A.
Laboratorios IMA

Market Size Split by Type
Oral Therapy
Injectable Therapy
Market Size Split by Application
Targeted Therapy
Chemotherapy
Hormonal Therapy
Biologic Therapy

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Oncology Drugs market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Oncology Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Oncology Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Oncology Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Oncology Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Oncology Drugs are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Oncology Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
1.1 Oncology Drugs Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Oncology Drugs Market Size Growth Rate by Type
1.4.2 Oral Therapy
1.4.3 Injectable Therapy
1.5 Market by Application
1.5.1 Global Oncology Drugs Market Size Growth Rate by Application
1.5.2 Targeted Therapy
1.5.3 Chemotherapy
1.5.4 Hormonal Therapy
1.5.5 Biologic Therapy
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Oncology Drugs Market Size
2.1.1 Global Oncology Drugs Revenue 2016-2025
2.1.2 Global Oncology Drugs Sales 2016-2025
2.2 Oncology Drugs Growth Rate by Regions
2.2.1 Global Oncology Drugs Sales by Regions
2.2.2 Global Oncology Drugs Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Oncology Drugs Sales by Manufacturers
3.1.1 Oncology Drugs Sales by Manufacturers
3.1.2 Oncology Drugs Sales Market Share by Manufacturers
3.1.3 Global Oncology Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Oncology Drugs Revenue by Manufacturers
3.2.1 Oncology Drugs Revenue by Manufacturers (2016-2018)
3.2.2 Oncology Drugs Revenue Share by Manufacturers (2016-2018)
3.3 Oncology Drugs Price by Manufacturers
3.4 Oncology Drugs Manufacturing Base Distribution, Product Types
3.4.1 Oncology Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Oncology Drugs Product Category
3.4.3 Date of International Manufacturers Enter into Oncology Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Oncology Drugs Sales by Type
4.2 Global Oncology Drugs Revenue by Type
4.3 Oncology Drugs Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Oncology Drugs Breakdown Data by Application

6 North America
6.1 North America Oncology Drugs by Countries
6.1.1 North America Oncology Drugs Sales by Countries
6.1.2 North America Oncology Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Oncology Drugs by Type
6.3 North America Oncology Drugs by Application
6.4 North America Oncology Drugs by Company

7 Europe
7.1 Europe Oncology Drugs by Countries
7.1.1 Europe Oncology Drugs Sales by Countries
7.1.2 Europe Oncology Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Oncology Drugs by Type
7.3 Europe Oncology Drugs by Application
7.4 Europe Oncology Drugs by Company

8 Asia Pacific
8.1 Asia Pacific Oncology Drugs by Countries
8.1.1 Asia Pacific Oncology Drugs Sales by Countries
8.1.2 Asia Pacific Oncology Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Oncology Drugs by Type
8.3 Asia Pacific Oncology Drugs by Application
8.4 Asia Pacific Oncology Drugs by Company

9 Central & South America
9.1 Central & South America Oncology Drugs by Countries
9.1.1 Central & South America Oncology Drugs Sales by Countries
9.1.2 Central & South America Oncology Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Oncology Drugs by Type
9.3 Central & South America Oncology Drugs by Application
9.4 Central & South America Oncology Drugs by Company

10 Middle East and Africa
10.1 Middle East and Africa Oncology Drugs by Countries
10.1.1 Middle East and Africa Oncology Drugs Sales by Countries
10.1.2 Middle East and Africa Oncology Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Oncology Drugs by Type
10.3 Middle East and Africa Oncology Drugs by Application
10.4 Middle East and Africa Oncology Drugs by Company

11 Company Profiles
11.1 Novartis A.G
11.1.1 Novartis A.G Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Oncology Drugs
11.1.4 Oncology Drugs Product Description
11.1.5 Recent Development
11.2 Laboratrio Cristlia
11.2.1 Laboratrio Cristlia Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Oncology Drugs
11.2.4 Oncology Drugs Product Description
11.2.5 Recent Development
11.3 Medley Genomics
11.3.1 Medley Genomics Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Oncology Drugs
11.3.4 Oncology Drugs Product Description
11.3.5 Recent Development
11.4 F. Hoffmann-La Roche Ltd
11.4.1 F. Hoffmann-La Roche Ltd Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Oncology Drugs
11.4.4 Oncology Drugs Product Description
11.4.5 Recent Development
11.5 Icon Plc.
11.5.1 Icon Plc. Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Oncology Drugs
11.5.4 Oncology Drugs Product Description
11.5.5 Recent Development
11.6 Sanofi S.A.
11.6.1 Sanofi S.A. Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Oncology Drugs
11.6.4 Oncology Drugs Product Description
11.6.5 Recent Development
11.7 Laboratoires Pierre Fabre
11.7.1 Laboratoires Pierre Fabre Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Oncology Drugs
11.7.4 Oncology Drugs Product Description
11.7.5 Recent Development
11.8 Eurofarma Laboratrios S.A.
11.8.1 Eurofarma Laboratrios S.A. Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Oncology Drugs
11.8.4 Oncology Drugs Product Description
11.8.5 Recent Development
11.9 Ach Laboratrios Farmacuticos S.A.
11.9.1 Ach Laboratrios Farmacuticos S.A. Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Oncology Drugs
11.9.4 Oncology Drugs Product Description
11.9.5 Recent Development
11.10 Laboratorios IMA
11.10.1 Laboratorios IMA Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Oncology Drugs
11.10.4 Oncology Drugs Product Description
11.10.5 Recent Development

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Oncology Drugs Raw Material
13.1.2 Oncology Drugs Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Table

List of Tables and Figures

Figure Picture of Oncology Drugs
Figure Global Oncology Drugs Production (MT) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Oncology Drugs Production Market Share by Types (Product Category) in 2017
Figure Oral Therapy Product Picture
Table Major Manufacturers of Oral Therapy
Figure Injectable Therapy Product Picture
Table Major Manufacturers of Injectable Therapy
Table Global Oncology Drugs Market Size Growth Rate by Application 2018-2025 (MT)
Figure Targeted Therapy
Figure Chemotherapy
Figure Hormonal Therapy
Figure Biologic Therapy
Figure Oncology Drugs Report Years Considered
Figure Global Oncology Drugs Market Size 2016-2025 (Million US$)
Figure Global Oncology Drugs Sales 2016-2025 (MT)
Table Global Oncology Drugs Market Size by Regions 2016-2025 (MT) & (Million US$)
Table Global Oncology Drugs Sales by Regions 2016-2025 (MT)
Table Global Oncology Drugs Sales Market Share by Regions 2016-2025
Figure Global Oncology Drugs Sales Market Share by Regions 2016-2025
Figure 2017 Global Oncology Drugs Sales Market Share by Regions
Table Global Oncology Drugs Revenue by Regions 2016-2025 (Million US$)
Table Global Oncology Drugs Revenue Market Share by Regions 2016-2025
Figure Global Oncology Drugs Revenue Market Share by Regions 2016-2025
Figure 2017 Global Oncology Drugs Revenue Market Share by Regions
Table Global Oncology Drugs Sales by Manufacturers (2016-2018) (MT)
Table Global Oncology Drugs Sales Share by Manufacturers (2016-2018)
Figure Global Oncology Drugs Sales Share by Manufacturers in 2017
Table Oncology Drugs Revenue by Manufacturers (2016-2018) (Million US$)
Table Oncology Drugs Revenue Share by Manufacturers (2016-2018)
Figure Oncology Drugs Value Share by Manufacturers in 2017
Table Global Oncology Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Oncology Drugs Price (2016-2018) (USD/Kg)
Table Oncology Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Oncology Drugs Product Category
Table Date of International Manufacturers Enter into Oncology Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Oncology Drugs Sales by Type (2016-2025) (MT)
Table Global Oncology Drugs Sales Share by Type (2016-2025)
Figure Global Oncology Drugs Sales Market Share by Type (2016-2025)
Figure Global Oncology Drugs Sales Market Share by Type in 2017
Table Global Oncology Drugs Revenue by Type (2016-2025) (Million US$)
Table Global Oncology Drugs Revenue Share by Type (2016-2025)
Figure Global Oncology Drugs Revenue Market Share by Type (2016-2025)
Figure Global Oncology Drugs Revenue Market Share by Type in 2017
Table Oncology Drugs Price by Type 2013-2018 (USD/Kg)
Table Global Oncology Drugs Sales by Application (2016-2025) (MT)
Table Global Oncology Drugs Sales Share by Application (2016-2025)
Figure Global Sales Oncology Drugs Market Share by Application (2016-2025)
Figure Global Sales Oncology Drugs Market Share by Application (2016-2025)
Figure North America Oncology Drugs Sales Growth Rate 2016-2025 (MT)
Figure North America Oncology Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table North America Oncology Drugs Sales by Countries (2016-2025) (MT)
Table North America Oncology Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 North America Oncology Drugs Sales Market Share by Countries
Table North America Oncology Drugs Revenue by Countries (2016-2025) (Million US$)
Table North America Oncology Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Oncology Drugs Revenue Market Share by Countries
Figure United States Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure United States Oncology Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure Canada Oncology Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure Mexico Oncology Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table North America Oncology Drugs Sales by Type (2016-2025) (MT)
Table North America Oncology Drugs Sales Market Share by Type (2016-2025)
Figure 2017 North America Oncology Drugs Market Share by Type
Table North America Oncology Drugs Sales by Application (2016-2025) (MT)
Table North America Oncology Drugs Sales Market Share by Application (2016-2025)
Figure 2017 North America Oncology Drugs Market Share by Application
Table North America Oncology Drugs Sales by Company (2016-2018) (MT)
Table North America Oncology Drugs Sales Market Share by Company (2016-2018)
Figure North America Oncology Drugs Sales Market Share by Company in 2017
Figure Europe Oncology Drugs Sales Growth Rate 2016-2025 (MT)
Figure Europe Oncology Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Oncology Drugs Sales by Countries (2016-2025) (MT)
Table Europe Oncology Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Oncology Drugs Sales Market Share by Countries
Table Europe Oncology Drugs Revenue by Countries (2016-2025) (Million US$)
Table Europe Oncology Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Oncology Drugs Revenue Market Share by Countries
Figure Germany Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure Germany Oncology Drugs Revenue Growth Rate (2016-2025) (MT)
Figure France Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure France Oncology Drugs Revenue Growth Rate (2016-2025) (MT)
Figure UK Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure UK Oncology Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure Italy Oncology Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure Russia Oncology Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Oncology Drugs Sales by Type (2016-2025) (MT)
Table Europe Oncology Drugs Sales Market Share by Type (2016-2025)
Figure 2017 Europe Oncology Drugs Market Share by Type
Table Europe Oncology Drugs Sales by Application (2016-2025) (MT)
Table Europe Oncology Drugs Sales Market Share by Application (2016-2025)
Figure 2017 Europe Oncology Drugs Market Share by Application
Table Europe Oncology Drugs Sales by Company (2016-2018) (MT)
Table Europe Oncology Drugs Sales Market Share by Company (2016-2018)
Figure Europe Oncology Drugs Sales Market Share by Company in 2017
Figure Asia Pacific Oncology Drugs Sales Growth Rate 2016-2025 (MT)
Figure Asia Pacific Oncology Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Oncology Drugs Sales by Countries (2016-2025) (MT)
Table Asia Pacific Oncology Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Oncology Drugs Sales Market Share by Countries
Table Asia Pacific Oncology Drugs Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Oncology Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Oncology Drugs Revenue Market Share by Countries
Figure China Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure China Oncology Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure Japan Oncology Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure Korea Oncology Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure India Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure India Oncology Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure Australia Oncology Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure Indonesia Oncology Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure Malaysia Oncology Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure Philippines Oncology Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure Thailand Oncology Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure Vietnam Oncology Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure Singapore Oncology Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Oncology Drugs Sales by Type (2016-2025) (MT)
Table Asia Pacific Oncology Drugs Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Oncology Drugs Market Share by Type
Table Asia Pacific Oncology Drugs Sales by Application (2016-2025) (MT)
Table Asia Pacific Oncology Drugs Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Oncology Drugs Market Share by Application
Table Asia Pacific Oncology Drugs Sales by Company (2016-2018) (MT)
Table Asia Pacific Oncology Drugs Sales Market Share by Company (2016-2018)
Figure Asia Pacific Oncology Drugs Sales Market Share by Company in 2017
Figure Central & South America Oncology Drugs Sales Growth Rate 2016-2025 (MT)
Figure Central & South America Oncology Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Oncology Drugs Sales by Countries (2016-2025) (MT)
Table Central & South America Oncology Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Oncology Drugs Sales Market Share by Countries
Table Central & South America Oncology Drugs Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Oncology Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Oncology Drugs Revenue Market Share by Countries
Figure Brazil Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure Brazil Oncology Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure Argentina Oncology Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Oncology Drugs Sales by Type (2016-2025) (MT)
Table Central & South America Oncology Drugs Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Oncology Drugs Market Share by Type
Table Central & South America Oncology Drugs Sales by Application (2016-2025) (MT)
Table Central & South America Oncology Drugs Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Oncology Drugs Market Share by Application
Table Central & South America Oncology Drugs Sales by Company (2016-2018) (MT)
Table Central & South America Oncology Drugs Sales Market Share by Company (2016-2018)
Figure Central & South America Oncology Drugs Sales Market Share by Company in 2017
Figure Middle East and Africa Oncology Drugs Sales Growth Rate 2016-2025 (MT)
Figure Middle East and Africa Oncology Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Oncology Drugs Sales by Countries (2016-2025) (MT)
Table Middle East and Africa Oncology Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Oncology Drugs Sales Market Share by Countries
Table Middle East and Africa Oncology Drugs Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Oncology Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Oncology Drugs Revenue Market Share by Countries
Figure GCC Countries Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure GCC Countries Oncology Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure Turkey Oncology Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure Egypt Oncology Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure South Africa Oncology Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Oncology Drugs Sales by Type (2016-2025) (MT)
Table Middle East and Africa Oncology Drugs Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Oncology Drugs Market Share by Type
Table Middle East and Africa Oncology Drugs Sales by Application (2016-2025) (MT)
Table Middle East and Africa Oncology Drugs Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Oncology Drugs Market Share by Application
Table Middle East and Africa Oncology Drugs Sales by Company (2016-2018) (MT)
Table Middle East and Africa Oncology Drugs Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Oncology Drugs Sales Market Share by Company in 2017
Table Novartis A.G Company Details
Table Novartis A.G Oncology Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Novartis A.G Recent Development
Table Laboratrio Cristlia Company Details
Table Laboratrio Cristlia Oncology Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Laboratrio Cristlia Recent Development
Table Medley Genomics Company Details
Table Medley Genomics Oncology Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Medley Genomics Recent Development
Table F. Hoffmann-La Roche Ltd Company Details
Table F. Hoffmann-La Roche Ltd Oncology Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table F. Hoffmann-La Roche Ltd Recent Development
Table Icon Plc. Company Details
Table Icon Plc. Oncology Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Icon Plc. Recent Development
Table Sanofi S.A. Company Details
Table Sanofi S.A. Oncology Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Sanofi S.A. Recent Development
Table Laboratoires Pierre Fabre Company Details
Table Laboratoires Pierre Fabre Oncology Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Laboratoires Pierre Fabre Recent Development
Table Eurofarma Laboratrios S.A. Company Details
Table Eurofarma Laboratrios S.A. Oncology Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Eurofarma Laboratrios S.A. Recent Development
Table Ach Laboratrios Farmacuticos S.A. Company Details
Table Ach Laboratrios Farmacuticos S.A. Oncology Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Ach Laboratrios Farmacuticos S.A. Recent Development
Table Laboratorios IMA Company Details
Table Laboratorios IMA Oncology Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Laboratorios IMA Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Oncology Drugs Value Chain
Table Typical Suppliers of Key Oncology Drugs Raw Material
Table Oncology Drugs Customers List
Table Oncology Drugs Sales Channels
Table Oncology Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *